PINOVA Capital to invest in NEUROMEDEX.

PINOVA Capital, an independent private equity firm, agreed to invest in NEUROMEDEX, a company specializing in the development and production of disposable neurosurgical products. Financial terms were not disclosed. "We are pleased to support Mr. Geyer in his company succession and are excited to lead this unique company into the next growth phase. As managing director and long-term senior employee, Markus Drewes, who has invested in the company alongside us, will significantly shape the course of success for the coming years. Together, we will further tap the growth potential of NEUROMEDEX within Europe and the rest of the world. We are very much looking forward to working together with him and the team," David Gilli, PINOVA Capital Director.